NCT05791994 EVASION: Effect of VisuAl Stimulation on attentION
| NCT ID | NCT05791994 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Angers |
| Condition | Mild Cognitive Impairment |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-07-01 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-07-01 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main objective is to compare changes in information processing speed after 30 days of intervention in participants with a dysexecutive mild cognitive impairment (MCI) and receiving either cognitive stimulation by adapted visual exercises (Emeraude® software) or the broadcasting of a television program without cognitive stimulation. Secondary objectives are: * To compare, after 30 days of intervention, in participants with a dysexecutive MCI and receiving either cognitive stimulation by adapted visual exercises (Emeraude® software), or the broadcasting of a television program without cognitive stimulation : * changes in information processing speed of each subtest, * changes in cognitive performance, * changes in executive functions, * changes in walking performance. * To compare the quality of life, after 30 days of intervention, of participants with a dysexecutive MCI and receiving either cognitive stimulation by adapted visual exercises (Emeraude® software) or the broadcasting of a television program without cognitive stimulation. * In the "Intervention" group, to study correlations between changes in information processing speed index and the final level reached for each cognitive stimulation exercise.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 60 years * Diagnosis of mild cognitive impairment of a dysexecutive or multidomain dysexecutive nature, according to Winblad consensus criteria * Presence of an informal caregiver * Subject gave and signed informed consent to participate in the study * Affiliation to a social security scheme Exclusion Criteria: * Presence of severe depressive symptoms (4-item Geriatric Depression Scale score \> 2) * Ophthalmological or central pathology that may affect the performance of stimulation exercises * Regular use of psychotropic drugs that may have an impact on the performance of stimulation exercises, in the opinion of the investigator (benzodiazepines, antidepressants, neuroleptics, hypnotics) * Use of anticonvulsant drugs * Existence of a confusional syndrome * Participation in another simultaneous clinical trial * Person deprived of liberty by judicial or administrative decision * Person under forced psychiatric care * Person subject to a legal protection measure * Person unable to give consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05791994 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Mild Cognitive Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05791994 currently recruiting?
Yes, NCT05791994 is actively recruiting participants. Contact the research team at marine.asfar@chu-angers.fr for enrollment information.
Where is the NCT05791994 trial being conducted?
This trial is being conducted at Angers, France.
Who is sponsoring the NCT05791994 clinical trial?
NCT05791994 is sponsored by University Hospital, Angers. The trial plans to enroll 40 participants.